Long-term efficacy of sodium-glucose cotransporter 2 inhibitor therapy in preventing atrial fibrillation recurrence after catheter ablation in type 2 diabetes mellitus patients()

BACKGROUND: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) reduce new-onset atrial fibrillation (AF) in patients with type 2 diabetes mellitus (T2DM). We aimed to determine the long-term effects of SGLT2i on atrial tachyarrhythmia recurrence after catheter ablation (CA) in T2DM patients. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hao-Tien, Wo, Hung-Ta, Chang, Po-Cheng, Lee, Hui-Ling, Wen, Ming-Shien, Chou, Chung-Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272333/
https://www.ncbi.nlm.nih.gov/pubmed/37332966
http://dx.doi.org/10.1016/j.heliyon.2023.e16835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272333/
https://www.ncbi.nlm.nih.gov/pubmed/37332966
http://dx.doi.org/10.1016/j.heliyon.2023.e16835

Ejemplares similares